Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
Recruiting
N/A
Interventional Study
Excessive Hairiness
Vascular Lesion
Pigmented Lesions
Acne Vulgaris
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 85 (estimated)
- Sponsor
- Eurofeedback · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, its favorable cost and versatility in contrast to many singlespectrum lasers, has led to its rapid proliferation and use in a number of different clinical settings. As described in the literature, ANTHÉLIA medical device is intended to treat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult men or women
* Excessive Hairiness:
* Patient with unwanted hair on the body (legs, arms, bikini line, or axilla)
* Patient over 18 years.
* Patients with Fitzpatrick skin types from I to V.
* Women were required to be post-menopausal, surgically sterilized, or under a m…
Contacts